Gotowa bibliografia na temat „Anticancer drugs”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anticancer drugs”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Anticancer drugs"
D, Subba Reddy, Prasanthi G, Amruth Raj S, Hari Krishna T, Sowjanya K, and Shantha Kumari K. "EVALUATION OF ANTICANCER GENERIC DRUGS AND BRANDED DRUGS." Indian Research Journal of Pharmacy and Science 5, no. 1 (2018): 1378–91. http://dx.doi.org/10.21276/irjps.2018.5.1.16.
Pełny tekst źródłaReese, David M. "Anticancer drugs." Nature 378, no. 6557 (1995): 532. http://dx.doi.org/10.1038/378532c0.
Pełny tekst źródłaJorayev, Muhammadyusuf Abdurakhim ugli Juraev Mukhammadyusuf. "ANTICANCER DRUGS." INTERNATIONAL BULLETIN OF MEDICAL SCIENCES AND CLINICAL RESEARCH 3, no. 4 (2023): 114–17. https://doi.org/10.5281/zenodo.7854262.
Pełny tekst źródłaKutty, Dr A. V. M. "Usefulness of Phytochemicals as Anticancer Drugs." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 16, no. 1 (2019): 1–2. http://dx.doi.org/10.58739/jcbs/v09i1.7.
Pełny tekst źródłaAtkins, Joshua H., and Leland J. Gershell. "Selective anticancer drugs." Nature Reviews Drug Discovery 1, no. 7 (2002): 491–92. http://dx.doi.org/10.1038/nrd842.
Pełny tekst źródłaAtkins, Joshua H., and Leland J. Gershell. "Selective anticancer drugs." Nature Reviews Cancer 2, no. 9 (2002): 645–46. http://dx.doi.org/10.1038/nrc900.
Pełny tekst źródłaBibby, M. C. "Combretastatin anticancer drugs." Drugs of the Future 27, no. 5 (2002): 475. http://dx.doi.org/10.1358/dof.2002.027.05.668645.
Pełny tekst źródłaMeegan, Mary J., and Niamh M. O’Boyle. "Special Issue “Anticancer Drugs”." Pharmaceuticals 12, no. 3 (2019): 134. http://dx.doi.org/10.3390/ph12030134.
Pełny tekst źródłaCiarimboli, Giuliano. "Anticancer Platinum Drugs Update." Biomolecules 11, no. 11 (2021): 1637. http://dx.doi.org/10.3390/biom11111637.
Pełny tekst źródłaZhang, Jason Y. "Apoptosis-based anticancer drugs." Nature Reviews Drug Discovery 1, no. 2 (2002): 101–2. http://dx.doi.org/10.1038/nrd742.
Pełny tekst źródłaRozprawy doktorskie na temat "Anticancer drugs"
Apps, MIchael Garry. "Platinum anticancer drugs and drug delivery systems." Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/14409.
Pełny tekst źródłaKozlowska, Hanna. "Interaction of dexrazoxane with anticancer drugs." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0001/MQ32158.pdf.
Pełny tekst źródłaTao, Zhimin. "Analysis of cytotoxicity of anticancer drugs." Related electronic resource:, 2007. http://proquest.umi.com/pqdweb?did=1407688361&sid=4&Fmt=2&clientId=3739&RQT=309&VName=PQD.
Pełny tekst źródłaLiu, Tong. "The synthesis of novel anticancer drugs." Thesis, University of Glasgow, 2003. http://theses.gla.ac.uk/4464/.
Pełny tekst źródłaSong, Di. "Bladder tissue pharmacokinetics of anticancer drugs /." The Ohio State University, 1996. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487940308433249.
Pełny tekst źródłaRatcliffe, Andrew J. "Synthesis of non-mutagenic anticancer drugs." Thesis, University of Bath, 1987. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378598.
Pełny tekst źródłaPettersson, Hanna Ilse. "Quinolinequinones as anticancer agents." Thesis, University of Exeter, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249038.
Pełny tekst źródłaWang, Shining. "DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS." Diss., Temple University Libraries, 2008. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/2535.
Pełny tekst źródłaLeczkowska, Anna. "Non-covalent DNA-binding ruthenium anticancer drugs." Thesis, University of Birmingham, 2011. http://etheses.bham.ac.uk//id/eprint/1695/.
Pełny tekst źródłaYarema, Kevin J. (Kevin Jon). "Cellular responses to platinum-based anticancer drugs." Thesis, Massachusetts Institute of Technology, 1994. http://hdl.handle.net/1721.1/33495.
Pełny tekst źródłaKsiążki na temat "Anticancer drugs"
1938-, Pratt William B., and Pratt William B. 1938-, eds. The anticancer drugs. 2nd ed. Oxford University Press, 1994.
Znajdź pełny tekst źródłaGarth, Powis, ed. Anticancer drugs: Reactive metabolism and drug interactions. Pergamon Press, 1994.
Znajdź pełny tekst źródłaAvendaño, Carmen. Medicinal chemistry of anticancer drugs. Elsevier, 2008.
Znajdź pełny tekst źródłaConvention, United States Pharmacopeial. Fact sheets on anticancer drugs. National Cancer Institute [distributor], 1994.
Znajdź pełny tekst źródłaGarth, Powis, and Hacker Miles P, eds. The Toxicity of anticancer drugs. Pergamon Press, 1991.
Znajdź pełny tekst źródłaNational Cancer Institute (U.S.), ed. Fact sheets on anticancer drugs. National Cancer Institute, 1994.
Znajdź pełny tekst źródła1964-, Spencer Peter, and Holt Walter, eds. Anticancer drugs: Design, delivery and pharmacology. Nova Science Publishers, 2009.
Znajdź pełny tekst źródłaSaeidnia, Soodabeh. New Approaches to Natural Anticancer Drugs. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-14027-8.
Pełny tekst źródłaHacker, Miles P., John S. Lazo, and Thomas R. Tritton, eds. Organ Directed Toxicities of Anticancer Drugs. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-2023-4.
Pełny tekst źródłaHildebrand, Jerzy, ed. Neurological Adverse Reactions to Anticancer Drugs. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76142-3.
Pełny tekst źródłaCzęści książek na temat "Anticancer drugs"
Schacter, Lee, Marcel Rozencweig, Claude Nicaise, Renzo Canetta, Susan Kelley, and Laurie Smaldone. "Anticancer Drugs." In Early Phase Drug Evaluation in Man. Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_49.
Pełny tekst źródłaSchwab, Matthias, Elke Schaeffeler, and Hiltrud Brauch. "Anticancer Drugs." In Metabolism of Drugs and Other Xenobiotics. Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527630905.ch13.
Pełny tekst źródłaIsnard-Bagnis, Corinne, Vincent Launay-Vacher, Svetlana Karie, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_22.
Pełny tekst źródłaZhao, Le, Zengyi Shao, and Jacqueline V. Shanks. "Anticancer Drugs." In Industrial Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527807833.ch8.
Pełny tekst źródłaGanguly, A. K., and Sesha Sridevi Alluri. "Anticancer Drugs." In Medicinal Chemistry. CRC Press, 2021. http://dx.doi.org/10.1201/9781003182573-4.
Pełny tekst źródłaIsnard-Bagnis, Corinne, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer Netherlands, 2003. http://dx.doi.org/10.1007/1-4020-2586-6_18.
Pełny tekst źródłaCateni, Francesca, and Marina Zacchigna. "PEG–Anticancer Drugs." In Macromolecular Anticancer Therapeutics. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0507-9_6.
Pełny tekst źródłaKim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_7.
Pełny tekst źródłaKim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Alkylating Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_4.
Pełny tekst źródłaKim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Antimetabolic Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Anticancer drugs"
Shiranirad, Saba, and Zeynab Barzegar. "Predictive Modeling of Drug Release from Liposomal Nano-Anticancer Drugs Using Advanced Machine Learning Techniques and TreeSHAP for Interpretability." In 2025 Eighth International Women in Data Science Conference at Prince Sultan University (WiDS PSU). IEEE, 2025. https://doi.org/10.1109/wids-psu64963.2025.00052.
Pełny tekst źródłaMa, Liang, Jeremy Barker, Changchun Zhou, Biaoyang Lin, and Wei Li. "A Perfused Two-Chamber System for Anticancer Drug Screening." In ASME 2010 International Manufacturing Science and Engineering Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/msec2010-34326.
Pełny tekst źródłaSchiestl, Robert H., Michael Davoren, and Yelena Rivina. "Abstract 1793: Novel radiation mitigators and anticancer drugs." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1793.
Pełny tekst źródłaSettleman, Jeffrey E. "Abstract CN06-04: Reversible tolerance to anticancer drugs." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-cn06-04.
Pełny tekst źródłaSchiestl, Robert H., Yelena Rivina, and Michael Davoren. "Abstract 3729: Novel radiation mitigators and anticancer drugs." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3729.
Pełny tekst źródłaZhukovets, T. A., M. А. Khancheuski, I. V. Koktysh, E. I. Kvasyuk, and A. G. Sysa. "ANTIOXIDANT EFFECTS OF EMOXYPINE AS ADJUVANT OF ANTI-CANCER DRUGS." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2021. http://dx.doi.org/10.46646/sakh-2021-2-52-55.
Pełny tekst źródłaCao, Tingying, Xiangdong Gao, and Yueqing Gu. "Biodegradable polylactide microspheres containing anticancer drugs used as injectable drug delivery system." In 2007 IEEE/ICME International Conference on Complex Medical Engineering. IEEE, 2007. http://dx.doi.org/10.1109/iccme.2007.4381726.
Pełny tekst źródłaJ., Alex Mathew, and Nixon Raj N. "Insilico Docking Studies on Anticancer Drugs for Breast Cancer." In 2009 International Association of Computer Science and Information Technology - Spring Conference. IEEE, 2009. http://dx.doi.org/10.1109/iacsit-sc.2009.12.
Pełny tekst źródłaShrestha, Gajendra, Michael Xiao, Richard Robison, Larry L. St Clair, and Kim O'Neill. "Abstract 3220: Lichen derived polyphenols as potential anticancer drugs." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3220.
Pełny tekst źródłaRibeiro, Tatiane. "23 Evidence-based medicine challenges in new anticancer drugs." In EBM Live Abstracts, July 2019, Oxford, UK. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-ebmlive.104.
Pełny tekst źródłaRaporty organizacyjne na temat "Anticancer drugs"
Howard, David, Peter Bach, Ernst Berndt, and Rena Conti. Pricing in the Market for Anticancer Drugs. National Bureau of Economic Research, 2015. http://dx.doi.org/10.3386/w20867.
Pełny tekst źródłaZhang, Jian-Ting. Molecular Study of Interactions between P-Glycoprotein and Anticancer Drugs. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300162.
Pełny tekst źródłaInoue, Takashi, and Mamoru Narukawa. Anti-tumor efficacy of anti-PD-1/PD-L1 antibodies in combination with other anticancer drugs in solid tumors: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0004.
Pełny tekst źródłaBiswas, Kaustav, and Samuel J. Danishefsky. Synthesis of Epothilone Analogs: Toward the Development of Potent Anticancer Drugs. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada409475.
Pełny tekst źródłaFeltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada486569.
Pełny tekst źródłaFeltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada481424.
Pełny tekst źródłaBeerman, Terry A. Discovery of DNA Binding Anticancer Drugs That Target Oncogenic Transcription Factors Associated With Human Breast Cancer. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada403322.
Pełny tekst źródłaVenedicto, Melissa, and Cheng-Yu Lai. Facilitated Release of Doxorubicin from Biodegradable Mesoporous Silica Nanoparticles. Florida International University, 2021. http://dx.doi.org/10.25148/mmeurs.009774.
Pełny tekst źródłaMacedo, Luciana, and Linda Malkas. The Human Breast Cancer DNA Synthesome Can Serve as a Novel In Vitro Model System for Studying the Mechanism of Action of Anticancer Drugs. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada393926.
Pełny tekst źródłaJiang, Haiyan. The Human Breast Cancer Cell DNA Synthesome Can Serve as a Novel in Vitro Model System for Studying the Mechanism of Action of Anticancer Drugs. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada384124.
Pełny tekst źródła